Saulius Girnius
- Hematology top 10%
- Multiple Myeloma Research and Treatments 20
- Chronic Myeloid Leukemia Treatments 3
-
- Chronic Lymphocytic Leukemia Research 5
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
-
- Protein Degradation and Inhibitors 14
- Amyloidosis: Diagnosis, Treatment, Outcomes 13
-
- Peptidase Inhibition and Analysis 7
- Cancer Treatment and Pharmacology 4
- Co-authors
- Zeina NahlehGheorghe DorosDavid C. SeldinKaren QuillenVaishali SanchorawalaM SkinnerNikhil C. MunshiLaura M. Dember
- Cited by
- HematologyGeneticsNephrology
- Journals
- SHILAP Revista de lepidopterología (1 paper)Blood (14 papers)Journal of neurosurgery (1 paper)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Saulius Girnius
31 papers receiving 280 citations
Peers
Comparison fields: 5 of 52
- Hematology 85
- Genetics 49
- Nephrology 23
- Molecular Biology 188
- Oncology 70
Countries citing papers authored by Saulius Girnius
This map shows the geographic impact of Saulius Girnius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saulius Girnius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saulius Girnius more than expected).
Fields of papers citing papers by Saulius Girnius
This network shows the impact of papers produced by Saulius Girnius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saulius Girnius. The network helps show where Saulius Girnius may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Saulius Girnius, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2020 | 11 | |
| 4 | 2018 | 0 | |
| 5 | 2018 | 1 | |
| 6 | 2017 | 2 | |
| 7 | 2015 | 8 | |
| 8 | 2015 | 1 | |
| 9 | 2013 | 8 | |
| 10 | 2013 | 20 | |
| 11 | 2013 | 5 | |
| 12 | 2012 | 19 | |
| 13 | 2012 | 7 | |
| 14 | 2011 | 23 | |
| 15 | 2011 | 1 | |
| 16 | 2009 | 12 | |
| 17 | 2009 | 21 | |
| 18 | 2006 | 27 | |
| 19 | 2006 | 32 | |
| 20 | 2004 | 13 |
About Saulius Girnius
Saulius Girnius is a scholar working on Hematology, Genetics and Oncology, having authored 35 papers that have together received 285 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (20 papers), Protein Degradation and Inhibitors (14 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (13 papers), Peptidase Inhibition and Analysis (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), Cancer Treatment and Pharmacology (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (85 citations), Genetics (49 citations) and Nephrology (23 citations). Saulius Girnius has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Zeina Nahleh, Gheorghe Doros, David C. Seldin, Karen Quillen, Vaishali Sanchorawala, M Skinner, Nikhil C. Munshi, Laura M. Dember, William Barrett and Bruce Oakley. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Journal of neurosurgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.